Physician-supervised programs targeting the progressive decline of stem cell populations, growth factor signaling, and tissue repair mechanisms — using interventions supported by peer-reviewed clinical evidence.
Regenerative Support: Tissue Repair & Renewal
Physician-supervised programs targeting the progressive decline of stem cell populations, growth factor signaling, and tissue repair mechanisms — using interventions supported by peer-reviewed clinical evidence.
The Growth Hormone and IGF-1 Axis
Growth hormone (GH) and insulin-like growth factor 1 (IGF-1) are central regulators of tissue repair, muscle maintenance, bone density, and cellular regeneration. Both decline significantly with age: GH secretion decreases approximately 14% per decade after age 30, and IGF-1 falls from peak values reached in early adulthood.
This progressive decline contributes to sarcopenia, reduced healing capacity, increased adiposity, loss of bone mineral density, and impaired tissue regeneration. These changes are measurable and, in many cases, modifiable.
Direct GH supplementation in non-deficient adults carries significant side effects: edema (39%), arthralgias (41%), carpal tunnel syndrome (18%), and increased diabetes risk (6.1%). Advanced Vitality Group uses growth hormone secretagogues instead, which stimulate the body's own GH production with a more favorable safety profile for GH-insufficient patients.
What GH/IGF-1 Decline Causes
- Sarcopenia and muscle loss
- Reduced healing capacity
- Increased fat accumulation
- Loss of bone density
- Impaired tissue regeneration
Growth Hormone Secretagogues
Sermorelin (GHRH Analogue)
FDA-approved synthetic analogue of growth hormone-releasing hormone. Clinical data demonstrates improvements in body composition and sleep quality at doses of 0.2–0.3 mg/day. Well-established safety profile in physician-supervised use.
CJC-1295 / Ipamorelin
CJC-1295 is an extended half-life GHRH analogue; ipamorelin is a selective GH secretagogue with a favorable cortisol and prolactin profile. Phase 1 data shows sustained GH and IGF-1 elevations without the hormonal disruption seen with less selective agents.
Ibutamoren (MK-677)
Oral GH secretagogue studied in a 2-year randomized controlled trial (n=395). Demonstrated increased IGF-1 and GH levels but no functional outcome improvement, with increased CHF incidence. Highlights the importance of careful patient selection and monitoring.
Peptide Therapy for Tissue Repair
BPC-157
Animal studies on tendon and ligament healing. Limited published human RCTs. Investigational status disclosed to all patients.
TB-500 (Thymosin Beta-4)
Animal wound healing studies; Phase 2 cardiac trials completed. No regulatory approval for regenerative indications.
Sermorelin
FDA-approved for GH deficiency in children; adult off-label data supports use in GH-insufficient patients. Phase 2 human data available.
Ipamorelin / CJC-1295
Phase 1/2 data on GH and IGF-1 elevation. Used in growth hormone secretagogue protocols for tissue repair support.
Musculoskeletal Regeneration: Addressing Sarcopenia
Sarcopenia — progressive age-related loss of skeletal muscle mass and strength — begins as early as the third decade of life and accelerates significantly after age 60. It is associated with increased risk of falls, fractures, metabolic disease, and all-cause mortality.
The following evidence-based interventions form the foundation of our musculoskeletal regeneration protocols:
Progressive Resistance Training (Grade A)
The most powerful intervention for sarcopenia across all age groups. Systematic reviews consistently demonstrate improvements in muscle mass, strength, and functional capacity with structured progressive resistance programs.
Protein Optimization (Grade A)
Current evidence supports 1.0–1.2 g/kg/day for healthy older adults and 1.2–1.5 g/kg/day for those at nutritional risk. Leucine-rich protein sources are preferred for their superior capacity to stimulate muscle protein synthesis.
Testosterone Optimization (Grade A for Hypogonadal Men)
The Testosterone Trials demonstrated clinically significant improvements in lean mass, muscle strength, and physical function in men with confirmed hypogonadism. Physician-supervised testosterone therapy is a cornerstone intervention for eligible patients.
Frequently Asked Questions About Regenerative Support
Restore Your Body's Regenerative Capacity
Schedule a consultation to evaluate your growth factors, hormone levels, and tissue repair capacity.